<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effects on leucocyte motility of sulphasalazine (Salazopyrin) and its metabolites <z:chebi fb="0" ids="132842">sulphapyridine</z:chebi> and 5 amino-<z:chebi fb="4" ids="16914">salicylic acid</z:chebi> have been compared with those of <z:chebi fb="2" ids="8378">prednisolone</z:chebi> and <z:chebi fb="0" ids="49662">indomethacin</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Sulphasalazine, its active metabolite 5 amino-<z:chebi fb="4" ids="16914">salicylic acid</z:chebi>, and <z:chebi fb="2" ids="8378">prednisolone</z:chebi> are <z:hpo ids='HP_0000001'>all</z:hpo> potent inhibitors of leucocyte motility </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="132842">Sulphapyridine</z:chebi> and <z:chebi fb="0" ids="49662">indomethacin</z:chebi> are non-inhibitory </plain></SENT>
<SENT sid="3" pm="."><plain>Inhibition of leucocyte motility may explain why sulphasalazine and 5 amino-<z:chebi fb="4" ids="16914">salicylic acid</z:chebi> are effective in <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> while <z:chebi fb="0" ids="132842">sulphapyridine</z:chebi> is not </plain></SENT>
<SENT sid="4" pm="."><plain>The lack of effect of <z:chebi fb="0" ids="49662">indomethacin</z:chebi> suggests that this action of sulphasalazine does not involve inhibition of <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> synthesis </plain></SENT>
</text></document>